PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11042692-1	2000	Type I Interferon (IFN) and all-trans retinoic acid (RA) inhibit cell proliferation of squamous carcinoma cell lines (SCC).	Tretinoin	38-51	serpin family B member 3	Homo sapiens	118-121	
20659317-0	2010	Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts.	Tretinoin	11-15	serpin family B member 3	Homo sapiens	75-78	
20236590-3	2010	The differentiation of SCC cells were induced with all-trans-retinoic acid (ATRA).	Tretinoin	51-74	serpin family B member 3	Homo sapiens	23-26	
20236590-3	2010	The differentiation of SCC cells were induced with all-trans-retinoic acid (ATRA).	Tretinoin	76-80	serpin family B member 3	Homo sapiens	23-26	
11746830-5	2001	The vitamin A metabolite retinoic acid (RA) has been used as a chemotherapeutic drug in the treatment of SCC.	Tretinoin	25-38	serpin family B member 3	Homo sapiens	105-108	
11746830-5	2001	The vitamin A metabolite retinoic acid (RA) has been used as a chemotherapeutic drug in the treatment of SCC.	Tretinoin	40-42	serpin family B member 3	Homo sapiens	105-108	
11746830-7	2001	However, we previously found that treatment of SCC lines with inhibitory doses of RA sensitized cells to the proliferative effects of EGF.	Tretinoin	82-84	serpin family B member 3	Homo sapiens	47-50	
11237771-3	2001	A similar effect was observed with 13-cis retinoic acid (RA), which has been used in chemoprevention of SCC.	Tretinoin	57-59	serpin family B member 3	Homo sapiens	104-107	
11042692-1	2000	Type I Interferon (IFN) and all-trans retinoic acid (RA) inhibit cell proliferation of squamous carcinoma cell lines (SCC).	Tretinoin	53-55	serpin family B member 3	Homo sapiens	118-121	
11042692-3	2000	In combination treatment RA potentiates IFN-beta effect in SCC ME-180 but not in SiHa cell line, partially resistant to RA antiproliferative action.	Tretinoin	25-27	serpin family B member 3	Homo sapiens	59-62	
9989277-6	1999	In parallel with this, unesterified retinol and retinoic acid concentrations in SCC were significantly elevated over those in normal cells.	Tretinoin	48-61	serpin family B member 3	Homo sapiens	80-83	
9989277-10	1999	Challenging cells with increasing medium retinol concentrations resulted in dose-dependent increases in retinol and retinoic acid within SCC.	Tretinoin	116-129	serpin family B member 3	Homo sapiens	137-140	
9989277-13	1999	Consistent with increased substrate-driven retinoic acid synthesis in SCC, the expression of transglutaminase 1 was suppressed to a greater extent in the SCCs than in NHK, when cells were exposed to equivalent medium concentrations of retinol.	Tretinoin	43-56	serpin family B member 3	Homo sapiens	70-73	
7923565-3	1994	Because encapsulation of certain drugs in lipid vesicles (liposomes) has been shown to result in reduced toxic effects, we studied the in vitro interaction of liposome-encapsulated all-trans-retinoic acid (L-ATRA) with a SCC line (MDA 886Ln) and its multicellular tumor spheroid (MTS) model.	Tretinoin	181-204	serpin family B member 3	Homo sapiens	221-224